India needs to devise practical tests to develop 'botsimilar' on similar lines of biosimilars: Dr DBA Narayana
India needs to move towards developing practical and implementable tests that can give larger number of data points for the development of botanical biosimilars (Botsimilar) on similar lines that of biosimilars. The pharma industry in the country is making …